Zenas BioPharma, Inc. Foreign Currency Transaction Gain Loss After Tax
Zenas BioPharma, Inc. (ZBIO) reported Foreign Currency Transaction Gain Loss After Tax of $300.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossAfterTax · last filed 2026-03-16
- Zenas BioPharma, Inc. foreign currency transaction gain loss after tax for fiscal 2025 was $300.00K.
- Zenas BioPharma, Inc. foreign currency transaction gain loss after tax for fiscal 2024 was -$200.00K.
- Zenas BioPharma, Inc. foreign currency transaction gain loss after tax for fiscal 2023 was -$100.00K.
| Period end | Foreign Currency Transaction Gain Loss After Tax 12 month |
|---|---|
| 2025-12-31 | $300.00K 10-K · filed 2026-03-16 |
| 2024-12-31 | -$200.00K 10-K · filed 2026-03-16 |
| 2023-12-31 | -$100.00K 10-K · filed 2025-03-11 |